Current Progress of Avian Vaccines Against West Nile Virus

Birds are the main natural host of West Nile virus (WNV), the worldwide most distributed mosquito-borne flavivirus, but humans and equids can also be sporadic hosts. Many avian species have been reported as susceptible to WNV, particularly corvids. In the case that clinical disease develops in birds...

Full description

Bibliographic Details
Main Authors: Nereida Jiménez de Oya, Estela Escribano-Romero, Ana-Belén Blázquez, Miguel A. Martín-Acebes, Juan-Carlos Saiz
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/4/126
_version_ 1811186272727728128
author Nereida Jiménez de Oya
Estela Escribano-Romero
Ana-Belén Blázquez
Miguel A. Martín-Acebes
Juan-Carlos Saiz
author_facet Nereida Jiménez de Oya
Estela Escribano-Romero
Ana-Belén Blázquez
Miguel A. Martín-Acebes
Juan-Carlos Saiz
author_sort Nereida Jiménez de Oya
collection DOAJ
description Birds are the main natural host of West Nile virus (WNV), the worldwide most distributed mosquito-borne flavivirus, but humans and equids can also be sporadic hosts. Many avian species have been reported as susceptible to WNV, particularly corvids. In the case that clinical disease develops in birds, this is due to virus invasion of different organs: liver, spleen, kidney, heart, and mainly the central nervous system, which can lead to death 24–48 h later. Nowadays, vaccines have only been licensed for use in equids; thus, the availability of avian vaccines would benefit bird populations, both domestic and wild ones. Such vaccines could be used in endangered species housed in rehabilitation and wildlife reserves, and in animals located at zoos and other recreational installations, but also in farm birds, and in those that are grown for hunting and restocking activities. Even more, controlling WNV infection in birds can also be useful to prevent its spread and limit outbreaks. So far, different commercial and experimental vaccines (inactivated, attenuated, and recombinant viruses, and subunits and DNA-based candidates) have been evaluated, with various regimens, both in domestic and wild avian species. However, there are still disadvantages that must be overcome before avian vaccination can be implemented, such as its cost-effectiveness for domestic birds since in many species the pathogenicity is low or zero, or the viability of being able to achieve collective immunity in wild birds in freedom. Here, a comprehensive review of what has been done until now in the field of avian vaccines against WNV is presented and discussed.
first_indexed 2024-04-11T13:43:51Z
format Article
id doaj.art-28df72eb6c4c4c179bd82267cf02de28
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-11T13:43:51Z
publishDate 2019-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-28df72eb6c4c4c179bd82267cf02de282022-12-22T04:21:10ZengMDPI AGVaccines2076-393X2019-09-017412610.3390/vaccines7040126vaccines7040126Current Progress of Avian Vaccines Against West Nile VirusNereida Jiménez de Oya0Estela Escribano-Romero1Ana-Belén Blázquez2Miguel A. Martín-Acebes3Juan-Carlos Saiz4Department of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, SpainDepartment of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, SpainDepartment of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, SpainDepartment of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, SpainDepartment of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, SpainBirds are the main natural host of West Nile virus (WNV), the worldwide most distributed mosquito-borne flavivirus, but humans and equids can also be sporadic hosts. Many avian species have been reported as susceptible to WNV, particularly corvids. In the case that clinical disease develops in birds, this is due to virus invasion of different organs: liver, spleen, kidney, heart, and mainly the central nervous system, which can lead to death 24–48 h later. Nowadays, vaccines have only been licensed for use in equids; thus, the availability of avian vaccines would benefit bird populations, both domestic and wild ones. Such vaccines could be used in endangered species housed in rehabilitation and wildlife reserves, and in animals located at zoos and other recreational installations, but also in farm birds, and in those that are grown for hunting and restocking activities. Even more, controlling WNV infection in birds can also be useful to prevent its spread and limit outbreaks. So far, different commercial and experimental vaccines (inactivated, attenuated, and recombinant viruses, and subunits and DNA-based candidates) have been evaluated, with various regimens, both in domestic and wild avian species. However, there are still disadvantages that must be overcome before avian vaccination can be implemented, such as its cost-effectiveness for domestic birds since in many species the pathogenicity is low or zero, or the viability of being able to achieve collective immunity in wild birds in freedom. Here, a comprehensive review of what has been done until now in the field of avian vaccines against WNV is presented and discussed.https://www.mdpi.com/2076-393X/7/4/126birdsvaccinesWest Nile virusflavivirusherd immunity
spellingShingle Nereida Jiménez de Oya
Estela Escribano-Romero
Ana-Belén Blázquez
Miguel A. Martín-Acebes
Juan-Carlos Saiz
Current Progress of Avian Vaccines Against West Nile Virus
Vaccines
birds
vaccines
West Nile virus
flavivirus
herd immunity
title Current Progress of Avian Vaccines Against West Nile Virus
title_full Current Progress of Avian Vaccines Against West Nile Virus
title_fullStr Current Progress of Avian Vaccines Against West Nile Virus
title_full_unstemmed Current Progress of Avian Vaccines Against West Nile Virus
title_short Current Progress of Avian Vaccines Against West Nile Virus
title_sort current progress of avian vaccines against west nile virus
topic birds
vaccines
West Nile virus
flavivirus
herd immunity
url https://www.mdpi.com/2076-393X/7/4/126
work_keys_str_mv AT nereidajimenezdeoya currentprogressofavianvaccinesagainstwestnilevirus
AT estelaescribanoromero currentprogressofavianvaccinesagainstwestnilevirus
AT anabelenblazquez currentprogressofavianvaccinesagainstwestnilevirus
AT miguelamartinacebes currentprogressofavianvaccinesagainstwestnilevirus
AT juancarlossaiz currentprogressofavianvaccinesagainstwestnilevirus